CCTR Presents: Emma Wren and Sharon Kane, hope from the UK

Emma Wren of  Alford UK, explains the realities of a DIPG diagnosis for her daughter Keira, and the experimental program with which Keira is involved to combat the deadly disease.  Sharon Kane of “Funding Neuro”, joins us to discuss the technical details of the procedure and the origins of this research, and Funding Neuro.  The fate of Keira’s future peers with brain cancer rests upon her pioneering journey.